Pfizer and its partner Avillion LLP have announced the results from the BFORE clinical study. Read More »

Sandoz's generic version of Latisse, bimatoprost ophthalmic solution, 0.03 percent, is now available in the United States. Read More »

Baxter International Inc. has once again earned the highest possible score of 100 percent on the 2017 Corporate Equality Index, which is produced by the Human Rights Campaign Foundation. Read More »

Endo International and BioDelivery Sciences International (BDSI) have agreed to return the BELBUCA buccal film product to BDSI. Read More »

Kite Pharma recently presented the results of its ZUMA-1 clinical trial involving axicabtagene ciloleucel (KTE-C19) at the American Society of Hematology (ASH) 58th Annual Meeting. Read More »

Voluntis has received FDA 510(k) clearance for Insulia, which also received the CE Mark for the treatment of Type 2 diabetes in adult patients that have had previous basal insulin treatments. Read More »

CTI BioPharma Corp.'s data from its PERSIST-2 Phase 3 clinical study was presented as a late-breaking oral session at the 58th American Society of Hematology Annual Meeting, which was held in San Diego Dec. 3-6. Read More »

The CVS Health Institute and the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response recently released research showing that automated notifications sent out by pharmacies are helping patients with chronic conditions remember to refill their medications before forecast natural disasters hit. Read More »

As National Influenza Vaccination Week runs through Saturday, CVS Pharmacy is reminding families across the U.S. that it is not too late to get their flu shots. Read More »

Rite Aid has announced that their customers will be able to save $5 on flu shots during National Influenza Vaccination Week in support of the cause. Read More »

Amgen presented data from its Phase 3 TOWER study at the 58th Annual Meeting and Exposition of the American Society of Hematology this week in San Diego. Read More »

OptumRx and CVS Pharmacy say their collaboration that will provide improved health outcomes that are cost-efficient for consumers and clients while giving them more suitable choices. Read More »

Eisai Inc. has released the final results of its Phase 3 rufinamide study, an open-label, two-year investigation. Read More »

Cigna will be implementing an integrated hi-tech/hi-touch approach when it comes to the support and service of its customers. Read More »

Omnicell has finalized an agreement for the acquisition of Ateb Inc. and its affiliate, Ateb Canada Ltd. Read More »

To kick off the holiday season, Cigna has released “Holiday Survival Tips.” Read More »

The American Journal of Health-System Pharmacy has launched its redesigned website, AJHP.org. Read More »

The American Society of Health System Pharmacists is accepting applications for its 2017 ASHP Executive Residency in Association Leadership and Management. Read More »

Amgen will partner with Janssen Biotech to assess the drug combination made up of KYPROLIS, developed by Amgen, and DARZALEX, developed by Janssen, over the course of multiple clinical trials for the treatment of patients who have multiple myeloma. Read More »

Cigna is asking medical groups to join the effort of decreasing opioid use by 25 percent by signing a pledge to reduce opioid prescriptions and treat opioid abuse as a chronic condition. Read More »